The Drug Discovery World Podcast

The Drug Discovery World Podcast

By Drug Discovery World (DDW)ScienceMedicineHealth & FitnessLife Sciences
Download on the App Store

The Drug Discovery World Podcast episodes

  • Could protein biologics be a pioneering approach in ophthalmology?

    The latest episode of the DDW 'In Conversation With' series is available to listen to below.

    This week, Bruno Quinney speaks to Reuben Dawkins, CEO of Link Biologics, a company developing protein biologics to treat inflammatory and degenerative conditions. Link is currently developing treatments for Dry Eye Disease and Wet AMD.

    Bruno chats to Reuben about why Link chose to target Dry Eye Disease with its pioneering approach, how the company saw an opportunity to compete with current treatments for Wet AMD, and whether the science behind Link's protein biologics could be used beyond ophthalmology.

    You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

    25 min
  • DDW Highlights: 14 July 2026

    The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

    Last week, a nanoparticle vaccine showed potential to protect from a 'tripledemic'. Elsewhere, could 'magic mushrooms' treat anorexia?

    You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

    15 min
  • DDW Highlights: 7 July 2026

    The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

    Last week, experts warned patients were being denied access to personalised cancer care. Cancer research was a theme elsewhere, with findings emerging from studies into a CAR T-cell therapy, lung cancer and breast cancer.

    You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

    18 min
  • How AI has revolutionised clinical development

    The latest episode of the DDW 'In Conversation With' series is available to listen to below.

    This week, Bruno Quinney speaks to Suzanne Caruso, President of Strategic Intelligence and Clinical & Regulatory at Norstella. Norstella supports drug developers looking to take their treatments from pipeline to patients, finding solutions to complexities in the drug development timeline. One of these solutions is AI.

    Suzanne discusses what it means for a company to be 'AI-native', how the combination of AI and Real World Data is transforming clinical development, and how AI is enabling companies to get treatments to patients faster.

    You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

    19 min
  • DDW Highlights: 30 June 2026

    The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

    Last week, researchers uncovered clues explaining risks of heart disease, lung disease, Covid-19 and cancer. Elsewhere, find out what is included in the latest issue of DDW.

    You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

    17 min
  • DDW Highlights: 23 June 2026

    The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

    Last week, results showed the new Wegovy pill could help patients lose 17% of their body weight. Elsewhere, advances were made in both cancer treatment and cancer research.

    You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

    13 min
  • Could a new weight loss approach have longer term benefits than GLP-1s?

    The latest episode of the DDW 'In Conversation With' series is available to listen to below.

    This week, Bruno Quinney speaks to Vincent Marion, Scientific Founder and President of AdipoPharma. AdipoPharma is a biotech leveraging research on insulin resistance and adipose tissue biology, developing a new treatment for metabolic diseases.

    Vincent discusses what makes AdipoPharma's lead asset different from GLP-1s, why findings into fat tissue dysfunction have been less explored in drug development, and how AdipoPharma is competing in an industry where GLP-1s are becoming increasingly accessible.

    You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

    17 min
  • DDW Highlights: 16 June 2026

    The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

    Last week, new research showed anti-IL-1β drugs could prevent lung cancer. Elsewhere, the UK is set to benefit from specialised blood tests and funding for early-career researchers.

    You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

    15 min
  • DDW Highlights: 9 June 2026

    The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

    Last week, a cancer drug demonstrated it could reduce tumours by as much as 55%. Elsewhere, AI was a recurrent theme in both clinical trials and drug development.

    You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

    14 min
  • Could a new approach determine the future of cancer treatment?

    The latest episode of the DDW 'In Conversation With' series is available to listen to below.

    This week, Bruno Quinney speaks to Terry Connolly and Shinta Cheng from K36 Therapeutics. K36 is a company developing first-in-class cancer therapeutics and their current lead asset is a treatment for multiple myeloma patients.

    Bruno speaks to Terry and Shinta about how their NSD2 inhibitors can treat cancer, how their approach compares to other biotechs, and why K36's science could be applied to other therapeutic areas.

    You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

    21 min

About The Drug Discovery World Podcast

From the publisher's feed

Here at Drug Discovery World (DDW) we've been publishing articles written by leading experts in the Drug Discovery, Pharmaceutical, and BioPharmaceutical industries for over 20 years.

More shows like The Drug Discovery World Podcast

Fareed Zakaria GPS by CNN Podcasts

Fareed Zakaria GPS

3,386 Listeners

The Daily by The New York Times

The Daily

111,865 Listeners

Biotech 2050 Podcast by Biotech 2050

Biotech 2050 Podcast

62 Listeners